Myxoma historical perspective

Jump to: navigation, search

Myxoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myxoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myxoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myxoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myxoma historical perspective

CDC on Myxoma historical perspective

Myxoma historical perspective in the news

Blogs on Myxoma historical perspective

Directions to Hospitals Treating Myxoma

Risk calculators and risk factors for Myxoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Cardiac myxoma was first described in 1845. In 1951, Prichard described a kind of microscopic endocardial structure of the atrial septum, which was suggested to be associated with cardiac myxoma. Clarence Crafoord, a Swedish cardiovascular surgeon successfully removed a cardiac myxoma for the first time in 1954. Before 1951, cardiac myxoma diagnosis was made only at post-mortem examination.

Historical perspective

  • In 1845, the first description of a left atrial myxoma was reported by King.[1]
  • In 1951, Prichard described a kind of microscopic endocardial structure of the atrial septum, which was suggested to be related to cardiac myxoma.[2] In the same year, intracardiac myxoma was recognized by angiography for the first time. Before 1951, cardiac myxoma diagnosis was made only at autopsy.
  • In 1959, the first M-mode echocardiogram was used to diagnose a left atrial myxoma.[3]
  • In 2000, gene mutation PRKAR1A was first identified in the pathogenesis of cardiac myxoma syndromes, such as; LAMB (lentigines, atrial myxoma, mucocutaneous myxomas and blue nevi), NAME (nevi, atrial myxoma, mucinosis of the skin, and endocrine overactivity), and Carney complex (myxomas, spotty skin pigmentation and endocrine overactivity).[4][5]

Landmark Events in the Development of Treatment Strategies

  • In 1954, Clarence Crafoord (1899 – 1984), a Swedish cardiovascular surgeon, successfully removed a cardiac myxoma for the first time. This case also represents the first extirpation of a cardiac tumor on cardiopulmonary support.[6]

References

  1. King TW. On simple vascular growths in the left auricle of the heart. Lancet 1845; 2:428-9
  2. Amano J, Kono T, Wada Y, Zhang T, Koide N, Fujimori M, Ito K (2003). "Cardiac myxoma: its origin and tumor characteristics". Ann Thorac Cardiovasc Surg. 9 (4): 215–21. PMID 13129418.
  3. Pinede L, Duhaut P, Loire R (2001). "Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases". Medicine (Baltimore). 80 (3): 159–72. PMID 11388092.
  4. Carney JA, Hruska LS, Beauchamp GD, Gordon H (1986). "Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity". Mayo Clin. Proc. 61 (3): 165–72. PMID 3945116.
  5. Mabuchi T, Shimizu M, Ino H, Yamguchi M, Terai H, Fujino N, Nagata M, Sakata K, Inoue M, Yoneda T, Mabuchi H (2005). "PRKAR1A gene mutation in patients with cardiac myxoma". Int. J. Cardiol. 102 (2): 273–7. doi:10.1016/j.ijcard.2004.05.053. PMID 15982496.
  6. Chitwood WR (1992). "Clarence Crafoord and the first successful resection of a cardiac myxoma". Ann. Thorac. Surg. 54 (5): 997–8. PMID 1417305.

Linked-in.jpg